Cargando…

Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies

Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Christoph, Jacob, Anette, Tonack, Sarah, Radon, Tomasz P., Sill, Martin, Zucknick, Manuela, Rüffer, Sven, Costello, Eithne, Neoptolemos, John P., Crnogorac-Jurcevic, Tatjana, Bauer, Andrea, Fellenberg, Kurt, Hoheisel, Jörg D.
Formato: Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877986/
https://www.ncbi.nlm.nih.gov/pubmed/20164060
http://dx.doi.org/10.1074/mcp.M900419-MCP200
_version_ 1782181833569468416
author Schröder, Christoph
Jacob, Anette
Tonack, Sarah
Radon, Tomasz P.
Sill, Martin
Zucknick, Manuela
Rüffer, Sven
Costello, Eithne
Neoptolemos, John P.
Crnogorac-Jurcevic, Tatjana
Bauer, Andrea
Fellenberg, Kurt
Hoheisel, Jörg D.
author_facet Schröder, Christoph
Jacob, Anette
Tonack, Sarah
Radon, Tomasz P.
Sill, Martin
Zucknick, Manuela
Rüffer, Sven
Costello, Eithne
Neoptolemos, John P.
Crnogorac-Jurcevic, Tatjana
Bauer, Andrea
Fellenberg, Kurt
Hoheisel, Jörg D.
author_sort Schröder, Christoph
collection PubMed
description Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, representing 810 antibodies that were directed at 741 cancer-related proteins. In addition to measures of array quality, we implemented indicators for the accuracy and significance of dual-color detection. Dual-color measurements outperform a single-color approach concerning assay reproducibility and discriminative power. In the analysis of serum samples, depletion of high-abundance proteins did not improve technical assay quality. On the contrary, depletion introduced a strong bias in protein representation. In an initial study, we demonstrated the applicability of the protocols to proteins derived from urine samples. We identified differences between urine samples from pancreatic cancer patients and healthy subjects and between sexes. This study demonstrates that biomedically relevant data can be produced. As demonstrated by the thorough quality analysis, the dual-color antibody array approach proved to be competitive with other proteomic techniques and comparable in performance to transcriptional microarray analyses.
format Text
id pubmed-2877986
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-28779862010-06-02 Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies Schröder, Christoph Jacob, Anette Tonack, Sarah Radon, Tomasz P. Sill, Martin Zucknick, Manuela Rüffer, Sven Costello, Eithne Neoptolemos, John P. Crnogorac-Jurcevic, Tatjana Bauer, Andrea Fellenberg, Kurt Hoheisel, Jörg D. Mol Cell Proteomics Research Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, representing 810 antibodies that were directed at 741 cancer-related proteins. In addition to measures of array quality, we implemented indicators for the accuracy and significance of dual-color detection. Dual-color measurements outperform a single-color approach concerning assay reproducibility and discriminative power. In the analysis of serum samples, depletion of high-abundance proteins did not improve technical assay quality. On the contrary, depletion introduced a strong bias in protein representation. In an initial study, we demonstrated the applicability of the protocols to proteins derived from urine samples. We identified differences between urine samples from pancreatic cancer patients and healthy subjects and between sexes. This study demonstrates that biomedically relevant data can be produced. As demonstrated by the thorough quality analysis, the dual-color antibody array approach proved to be competitive with other proteomic techniques and comparable in performance to transcriptional microarray analyses. The American Society for Biochemistry and Molecular Biology 2010-06 2010-02-16 /pmc/articles/PMC2877986/ /pubmed/20164060 http://dx.doi.org/10.1074/mcp.M900419-MCP200 Text en © 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles
spellingShingle Research
Schröder, Christoph
Jacob, Anette
Tonack, Sarah
Radon, Tomasz P.
Sill, Martin
Zucknick, Manuela
Rüffer, Sven
Costello, Eithne
Neoptolemos, John P.
Crnogorac-Jurcevic, Tatjana
Bauer, Andrea
Fellenberg, Kurt
Hoheisel, Jörg D.
Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title_full Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title_fullStr Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title_full_unstemmed Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title_short Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
title_sort dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877986/
https://www.ncbi.nlm.nih.gov/pubmed/20164060
http://dx.doi.org/10.1074/mcp.M900419-MCP200
work_keys_str_mv AT schroderchristoph dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT jacobanette dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT tonacksarah dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT radontomaszp dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT sillmartin dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT zucknickmanuela dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT ruffersven dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT costelloeithne dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT neoptolemosjohnp dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT crnogoracjurcevictatjana dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT bauerandrea dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT fellenbergkurt dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies
AT hoheiseljorgd dualcolorproteomicprofilingofcomplexsampleswithamicroarrayof810cancerrelatedantibodies